Palliative vasoactive therapy in patients with septic shock

Chest

Volumn 146, Issue 3, 2014, Pages e107-e108

  Merceron, Sybille ^a   Canet, Emmanuel ^a   Lemiale, Virginie ^a   Azoulay, Elie ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NORADRENALIN;

CANCER CHEMOTHERAPY; DECISION MAKING; ENDOTRACHEAL INTUBATION; HOSPITAL ADMISSION; HUMAN; LETTER; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NON INVASIVE PROCEDURE; PALLIATIVE THERAPY; SEPTIC SHOCK; SURVIVAL RATE; CRITICAL ILLNESS; FEMALE; INTENSIVE CARE; INTENSIVE CARE UNIT; LIVING WILL; MALE; MICROCLIMATE; PROCEDURES; RESUSCITATION; TRENDS; UTILIZATION;

ADVANCE DIRECTIVE ADHERENCE; CRITICAL CARE; CRITICAL ILLNESS; DECISION MAKING; FEMALE; HUMANS; INTENSIVE CARE UNITS; LIFE SUPPORT SYSTEMS; MALE; RESUSCITATION ORDERS;

EID: 84907194873     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0602     Document Type: Letter

References (9)

1. Corcoran JP, Rahman NM. Point: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? Yes. Chest. 2014; 145 (1): 14-17.
2. Colice GL, Idell S. Counterpoint: should fibrinolytics be routinely administered intrapleurally for management of a complicated parapneumonic effusion? No. Chest. 2014; 145 (1): 17-20.
3. Corcoran JP, Rahman NM. Rebuttal from Drs Corcoran and Rahman. Chest. 2014; 145 (1): 20-21.
4. Colice GL, Idell S. Rebuttal from Drs Colice and Idell. Chest. 2014; 145 (1): 21-23.
5. Maskell NA, Davies CW, Nunn AJ, et al; First Multicenter Intrapleural Sepsis Trial (MIST1) Group. UK Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005; 352 (9): 865-874.
6. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011; 365 (6): 518-526.
7. Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010; 137 (3): 536-543.
8. Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014; 145 (4): 848-855.
9. Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med. 2012; 106 (5): 716-723.